Peptides have moved from the fringe of performance optimization into mainstream conversation — partly because the same mechanisms that make GLP-1 drugs effective for weight loss are peptide-based, and partly because growth hormone secretagogues have demonstrated real-world results that are hard to ignore.
This is a crowded space with more hype than rigor. Here's an honest look at the peptides with meaningful evidence for fat loss, and what they actually do.
What Peptides Are (and Aren't)
Peptides are short chains of amino acids — essentially small proteins. Many naturally occurring biological signals in the body are peptides: insulin, GLP-1, glucagon, and dozens of others. Therapeutic peptides either mimic these natural signals, amplify them, or block them.
Peptides are not: - Anabolic steroids (entirely different mechanism and risk profile) - Supplements (they require prescription and injection in most cases) - Magic bullets (they work through the same physiological systems you can also optimize through sleep, training, and nutrition)
Most therapeutic peptides are injected subcutaneously (under the skin) because they would be degraded in the digestive tract. A few newer formulations use nasal delivery or oral capsules, but injection remains the standard for the most effective peptides.
The Best-Evidenced Peptides for Fat Loss
### 1. GLP-1 Receptor Agonists (Semaglutide, Tirzepatide)
These are the most evidence-backed peptides for fat loss by a large margin — and they happen to be FDA-approved medications available through telehealth.
Mechanism: GLP-1 is a natural gut peptide that signals satiety. GLP-1 receptor agonists mimic and amplify this signal, reducing appetite and slowing gastric emptying.
Results: In clinical trials, semaglutide produces average weight loss of 15-17% of body weight over 68 weeks. Tirzepatide (which adds GIP receptor agonism) produces average loss of 20-22%. These are the most effective pharmacological interventions for obesity ever tested.
### 2. Growth Hormone Secretagogues (Sermorelin, Ipamorelin/CJC-1295)
GH secretagogues stimulate the pituitary to release growth hormone through natural feedback mechanisms, rather than directly injecting growth hormone.
Sermorelin: A GHRH (growth hormone releasing hormone) analog. Stimulates GH release pulsatility. Well-studied, been in clinical use since the 1990s.
Ipamorelin/CJC-1295: A combination often prescribed together. Ipamorelin is a GHRP (growth hormone releasing peptide) that stimulates GH release; CJC-1295 extends the duration of action. Provides synergistic GH release with sustained effect.
For fat loss: Growth hormone directly promotes lipolysis (fat breakdown), particularly from visceral fat. It also promotes muscle protein synthesis, which preserves lean mass while losing fat — the combination problem that GLP-1 medications alone struggle with.
Clinical context: GH secretagogues are most impactful in adults with age-related GH decline (typically over 35-40), not in young adults with normal GH levels.
Expected results: Modest but real fat loss (particularly visceral), improved body composition, better recovery, improved sleep quality. Not dramatic on their own — meaningful as part of a comprehensive protocol.
### 3. AOD-9604 (Anti-Obesity Drug Fragment)
A synthetic analog of the fat-burning fragment of growth hormone. Originally developed by Monash University as a targeted weight loss peptide.
Mechanism: Stimulates lipolysis without the growth-promoting or metabolic effects of full growth hormone. More targeted for fat loss.
Research status: Passed Phase 2 trials for obesity, was designated generally recognized as safe by FDA for food use, but the Phase 3 trial program was not completed for obesity indication. Clinical data is encouraging but limited compared to the GLP-1 class.
Currently used in compounding practice for body composition, typically combined with other peptides.
### 4. BPC-157 (Body Protection Compound)
Not a fat loss peptide per se — but frequently combined with fat loss protocols because of its role in recovery and gut health.
BPC-157 is a peptide derived from a protein in gastric juice. It has significant healing and anti-inflammatory effects in animal studies: accelerating tendon and ligament repair, reducing inflammation, and supporting gut lining integrity.
For someone on a caloric deficit running a fat loss protocol, BPC-157 supports connective tissue recovery during increased training, reduces systemic inflammation that can blunt fat loss, and supports gut health (important for GLP-1 tolerance).
Evidence: Extensive preclinical data; limited human trials; widespread clinical use. The human evidence is thin but the animal data is robust and the side effect profile is favorable.
### 5. Tesamorelin
A GHRH analog specifically studied for visceral fat reduction. FDA-approved for HIV-associated lipodystrophy (a condition causing visceral fat accumulation).
For off-label use in men with visceral adiposity, tesamorelin has solid evidence for reducing visceral fat specifically — the metabolically dangerous fat around internal organs. More targeted and better-evidenced than ipamorelin/CJC-1295 for visceral fat specifically.
More expensive and harder to access than other GH secretagogues, but the evidence base is stronger.
How Peptides Fit a Fat Loss Protocol
The most rational approach to fat loss in 2026:
Foundation: GLP-1 medication (semaglutide or tirzepatide) + high protein + resistance training. This combination, done right, produces dramatic results.
Optimization layer: GH secretagogues (ipamorelin/CJC-1295 or tesamorelin) for muscle preservation and visceral fat reduction while on GLP-1.
Recovery support: BPC-157 if training intensely or managing inflammation.
Monitoring: Regular labs to track body composition markers, not just scale weight.
The peptide approach to fat loss is synergistic — each piece addresses a different mechanism. GLP-1 handles appetite; GH secretagogues handle lipolysis and muscle preservation; BPC-157 handles recovery capacity.
Accessing Peptides Legally
In the United States, most therapeutic peptides require a prescription from a licensed physician and must be obtained through a compounding pharmacy. The FDA has recently updated regulations around peptide compounding — some peptides that were previously widely available have faced new restrictions.
The current legal landscape (early 2026): - Sermorelin: Available via compounding with prescription - Ipamorelin/CJC-1295: Available via compounding with prescription - Tesamorelin: FDA-approved; available via prescription - BPC-157: In a regulatory gray zone; available via some compounding pharmacies - AOD-9604: Available via compounding
Working with a telehealth provider that has physician oversight and licensed pharmacy relationships is the correct approach.
Frequently Asked Questions
Are peptides safe for fat loss?
The evidence varies by peptide. GLP-1 medications have extensive safety data. GH secretagogues like sermorelin and ipamorelin/CJC-1295 have good safety profiles in available studies. BPC-157 has strong animal safety data with limited human trials. All carry unknown long-term risk profiles — which is why physician oversight and regular monitoring matter.
Do you need to inject peptides?
Most effective peptides are injected subcutaneously because they'd be degraded in the gut. GLP-1 medications like semaglutide are injected weekly. GH secretagogues are typically injected daily before sleep. Subcutaneous injection is straightforward and relatively painless with proper technique — most patients adapt quickly.
What is the best peptide to combine with semaglutide?
The most commonly used combination is semaglutide + ipamorelin/CJC-1295. GLP-1 handles appetite suppression and drives caloric deficit; GH secretagogues stimulate fat oxidation and muscle preservation. BPC-157 is added for gut health and recovery support. This stack addresses appetite, fat mobilization, and muscle retention simultaneously.
How long until peptides work for fat loss?
GLP-1 medications typically show meaningful appetite reduction within 1-2 weeks. GH secretagogues work more gradually — subjective improvements in sleep and recovery often appear in 2-4 weeks; body composition changes become visible at 8-12 weeks. Most comprehensive peptide protocols are evaluated at 3 months minimum.
Get our free Body Composition Guide
Protein protocols, workout structure, sleep optimization, and the supplement stack that actually works.
Get our free Body Composition Guide →
